Heart attack tester BG Medicine sees stock jump at week’s end
BG Medicine, which has created a biomarker test to determine heart-attack risk, saw its stock jump more than 10 percent on Friday. The company won FDA approval for its test by the end of last year and went public to fund the rollout.